MedTrace Logo

Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy Adults

NCT02181348 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 357

Last updated 2014-07-03

No results posted yet for this study

Summary

Anemia is one of the major health problems of the developing countries of the world \[1\]. According to the WHO reference criteria, an adult is labeled as anemic, if the blood hemoglobin concentration falls below 13.0 g/dL in men or less than 12.0 g/dL in the non-pregnant women \[2\]. Hemoglobin concentrations below the lower limit of normal are a common laboratory finding in apparently healthy people in general population all over the world \[3-5\]. Many of these mildly anemic individuals are not investigated sufficiently to establish the probable cause of their anemia and thus may end up with morbidity and health problems, especially the young women in developing countries \[4\].

Only few studies on the use of vitamin E in the correction of anemia have been published and hardly any on correction of mild anemia in healthy adults. The objective of this intervention study was to investigate the association of vitamin E supplementation with post-supplemental blood hemoglobin levels in mildly anemic healthy Pakistani adults.

Conditions

Interventions

DRUG

Vitamin E

dl-alpha tocopheryl acetate 400 mg once daily for 3 months

DRUG

placebo (edible oil)

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Dr. Tanveer Jilani, MBBS, M.Phil · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02181348 on ClinicalTrials.gov